(Q46891054)

26 December 2017

title

Homocysteine and risk in end-stage renal disease: a matter of context (English)

1 reference

26 December 2017

author

Carmine Zoccali

series ordinal

1

1 reference

26 December 2017

author name string

Mallamaci F

series ordinal

2

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

26 December 2017

published in

Kidney International

1 reference

26 December 2017

volume

69

1 reference

26 December 2017

issue

2

1 reference

26 December 2017

page(s)

204-206

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.ki.5000078

exact match

0 references

cites work

Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000078

7 January 2021

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000078

7 January 2021

Survival with first-line bosentan in patients with primary pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000078

7 January 2021

Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000078

7 January 2021

Homocysteine in uraemia--a puzzling and conflicting story

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000078

7 January 2021

Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000078

7 January 2021

Homocysteine binds to human plasma fibronectin and inhibits its interaction with fibrin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000078

7 January 2021

Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000078

7 January 2021

A low, rather than a high, total plasma homocysteine is an indicator of poor outcome in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000078

7 January 2021

Impact of malnutrition-inflammation on the association between homocysteine and mortality

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000078

7 January 2021

An MTHFR variant, homocysteine, and cardiovascular comorbidity in renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000078

7 January 2021

The methylentetrahydrofolate reductase C677T point mutation is a risk factor for vascular access thrombosis in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000078

7 January 2021

Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000078

7 January 2021

Acetylcysteine reduces plasma homocysteine concentration and improves pulse pressure and endothelial function in patients with end-stage renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000078

7 January 2021

The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000078

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5000078

1 reference

26 December 2017

PubMed ID

16408106

1 reference

26 December 2017